The beneficial metabolic effects of insulin sensitizers are not attenuated by mitochondrial pyruvate carrier 2 hypomorphism

Patrick A. Vigueira, Kyle S. McCommis, Wesley T. Hodges, George G. Schweitzer, Serena L. Cole, Lalita Oonthonpan, Eric B. Taylor, William G. McDonald, Rolf F. Kletzien, Jerry R. Colca, Brian N. Finck

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'The beneficial metabolic effects of insulin sensitizers are not attenuated by mitochondrial pyruvate carrier 2 hypomorphism'. Together they form a unique fingerprint.

Medicine & Life Sciences